nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2B6—Irinotecan—colon cancer	0.166	0.286	CbGbCtD
Efavirenz—CYP2C9—Capecitabine—colon cancer	0.142	0.244	CbGbCtD
Efavirenz—CYP1A2—Fluorouracil—colon cancer	0.0935	0.161	CbGbCtD
Efavirenz—CYP2C9—Fluorouracil—colon cancer	0.0842	0.145	CbGbCtD
Efavirenz—CYP3A4—Irinotecan—colon cancer	0.051	0.0878	CbGbCtD
Efavirenz—CYP3A4—Vincristine—colon cancer	0.0446	0.0767	CbGbCtD
Efavirenz—Myalgia—Vincristine—colon cancer	0.000771	0.00184	CcSEcCtD
Efavirenz—Cough—Irinotecan—colon cancer	0.00077	0.00184	CcSEcCtD
Efavirenz—Hyperglycaemia—Capecitabine—colon cancer	0.000764	0.00183	CcSEcCtD
Efavirenz—Hypertension—Irinotecan—colon cancer	0.000762	0.00182	CcSEcCtD
Efavirenz—Pneumonia—Capecitabine—colon cancer	0.00076	0.00182	CcSEcCtD
Efavirenz—Infestation NOS—Capecitabine—colon cancer	0.000755	0.00181	CcSEcCtD
Efavirenz—Infestation—Capecitabine—colon cancer	0.000755	0.00181	CcSEcCtD
Efavirenz—Depression—Capecitabine—colon cancer	0.000753	0.0018	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000749	0.00179	CcSEcCtD
Efavirenz—Renal failure—Capecitabine—colon cancer	0.000743	0.00177	CcSEcCtD
Efavirenz—Discomfort—Irinotecan—colon cancer	0.000742	0.00177	CcSEcCtD
Efavirenz—Neuropathy peripheral—Capecitabine—colon cancer	0.00074	0.00177	CcSEcCtD
Efavirenz—Jaundice—Capecitabine—colon cancer	0.000736	0.00176	CcSEcCtD
Efavirenz—Convulsion—Fluorouracil—colon cancer	0.000732	0.00175	CcSEcCtD
Efavirenz—Confusional state—Irinotecan—colon cancer	0.000726	0.00173	CcSEcCtD
Efavirenz—Nervous system disorder—Vincristine—colon cancer	0.000725	0.00173	CcSEcCtD
Efavirenz—Thrombocytopenia—Vincristine—colon cancer	0.000724	0.00173	CcSEcCtD
Efavirenz—Haematuria—Capecitabine—colon cancer	0.00072	0.00172	CcSEcCtD
Efavirenz—Myalgia—Fluorouracil—colon cancer	0.000719	0.00172	CcSEcCtD
Efavirenz—Chest pain—Fluorouracil—colon cancer	0.000719	0.00172	CcSEcCtD
Efavirenz—Hyperhidrosis—Vincristine—colon cancer	0.000715	0.00171	CcSEcCtD
Efavirenz—Hepatobiliary disease—Capecitabine—colon cancer	0.000714	0.00171	CcSEcCtD
Efavirenz—Discomfort—Fluorouracil—colon cancer	0.000711	0.0017	CcSEcCtD
Efavirenz—Shock—Irinotecan—colon cancer	0.000708	0.00169	CcSEcCtD
Efavirenz—Nervous system disorder—Irinotecan—colon cancer	0.000706	0.00169	CcSEcCtD
Efavirenz—Thrombocytopenia—Irinotecan—colon cancer	0.000705	0.00168	CcSEcCtD
Efavirenz—Anorexia—Vincristine—colon cancer	0.000705	0.00168	CcSEcCtD
Efavirenz—Hyperhidrosis—Irinotecan—colon cancer	0.000696	0.00166	CcSEcCtD
Efavirenz—Confusional state—Fluorouracil—colon cancer	0.000695	0.00166	CcSEcCtD
Efavirenz—Mood swings—Methotrexate—colon cancer	0.000691	0.00165	CcSEcCtD
Efavirenz—Anorexia—Irinotecan—colon cancer	0.000686	0.00164	CcSEcCtD
Efavirenz—Ataxia—Methotrexate—colon cancer	0.000686	0.00164	CcSEcCtD
Efavirenz—Rhinitis—Capecitabine—colon cancer	0.00068	0.00162	CcSEcCtD
Efavirenz—Hepatitis—Capecitabine—colon cancer	0.000678	0.00162	CcSEcCtD
Efavirenz—Nervous system disorder—Fluorouracil—colon cancer	0.000676	0.00162	CcSEcCtD
Efavirenz—Thrombocytopenia—Fluorouracil—colon cancer	0.000675	0.00161	CcSEcCtD
Efavirenz—Hypoaesthesia—Capecitabine—colon cancer	0.000675	0.00161	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Vincristine—colon cancer	0.000673	0.00161	CcSEcCtD
Efavirenz—Tachycardia—Fluorouracil—colon cancer	0.000673	0.00161	CcSEcCtD
Efavirenz—Urinary tract disorder—Capecitabine—colon cancer	0.00067	0.0016	CcSEcCtD
Efavirenz—Insomnia—Vincristine—colon cancer	0.000669	0.0016	CcSEcCtD
Efavirenz—Oedema peripheral—Capecitabine—colon cancer	0.000668	0.0016	CcSEcCtD
Efavirenz—Connective tissue disorder—Capecitabine—colon cancer	0.000666	0.00159	CcSEcCtD
Efavirenz—Urethral disorder—Capecitabine—colon cancer	0.000665	0.00159	CcSEcCtD
Efavirenz—Paraesthesia—Vincristine—colon cancer	0.000664	0.00159	CcSEcCtD
Efavirenz—Breast disorder—Methotrexate—colon cancer	0.000659	0.00158	CcSEcCtD
Efavirenz—Anorexia—Fluorouracil—colon cancer	0.000657	0.00157	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000657	0.00157	CcSEcCtD
Efavirenz—Visual impairment—Capecitabine—colon cancer	0.000654	0.00156	CcSEcCtD
Efavirenz—Insomnia—Irinotecan—colon cancer	0.000651	0.00156	CcSEcCtD
Efavirenz—Paraesthesia—Irinotecan—colon cancer	0.000646	0.00154	CcSEcCtD
Efavirenz—Decreased appetite—Vincristine—colon cancer	0.000643	0.00154	CcSEcCtD
Efavirenz—Dyspnoea—Irinotecan—colon cancer	0.000642	0.00153	CcSEcCtD
Efavirenz—Erythema multiforme—Capecitabine—colon cancer	0.000641	0.00153	CcSEcCtD
Efavirenz—Somnolence—Irinotecan—colon cancer	0.00064	0.00153	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Vincristine—colon cancer	0.000638	0.00153	CcSEcCtD
Efavirenz—Fatigue—Vincristine—colon cancer	0.000637	0.00152	CcSEcCtD
Efavirenz—Eye disorder—Capecitabine—colon cancer	0.000634	0.00151	CcSEcCtD
Efavirenz—Dyspepsia—Irinotecan—colon cancer	0.000634	0.00151	CcSEcCtD
Efavirenz—Tinnitus—Capecitabine—colon cancer	0.000632	0.00151	CcSEcCtD
Efavirenz—Constipation—Vincristine—colon cancer	0.000632	0.00151	CcSEcCtD
Efavirenz—Pain—Vincristine—colon cancer	0.000632	0.00151	CcSEcCtD
Efavirenz—Asthma—Methotrexate—colon cancer	0.000631	0.00151	CcSEcCtD
Efavirenz—Flushing—Capecitabine—colon cancer	0.000629	0.0015	CcSEcCtD
Efavirenz—Cardiac disorder—Capecitabine—colon cancer	0.000629	0.0015	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000628	0.0015	CcSEcCtD
Efavirenz—Decreased appetite—Irinotecan—colon cancer	0.000626	0.0015	CcSEcCtD
Efavirenz—Insomnia—Fluorouracil—colon cancer	0.000624	0.00149	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Irinotecan—colon cancer	0.000621	0.00149	CcSEcCtD
Efavirenz—Fatigue—Irinotecan—colon cancer	0.000621	0.00148	CcSEcCtD
Efavirenz—Paraesthesia—Fluorouracil—colon cancer	0.000619	0.00148	CcSEcCtD
Efavirenz—Pancreatitis—Methotrexate—colon cancer	0.000618	0.00148	CcSEcCtD
Efavirenz—Constipation—Irinotecan—colon cancer	0.000616	0.00147	CcSEcCtD
Efavirenz—Pain—Irinotecan—colon cancer	0.000616	0.00147	CcSEcCtD
Efavirenz—Angiopathy—Capecitabine—colon cancer	0.000615	0.00147	CcSEcCtD
Efavirenz—Dyspnoea—Fluorouracil—colon cancer	0.000615	0.00147	CcSEcCtD
Efavirenz—Somnolence—Fluorouracil—colon cancer	0.000613	0.00146	CcSEcCtD
Efavirenz—Immune system disorder—Capecitabine—colon cancer	0.000613	0.00146	CcSEcCtD
Efavirenz—Mediastinal disorder—Capecitabine—colon cancer	0.000611	0.00146	CcSEcCtD
Efavirenz—Dyspepsia—Fluorouracil—colon cancer	0.000607	0.00145	CcSEcCtD
Efavirenz—Arrhythmia—Capecitabine—colon cancer	0.000606	0.00145	CcSEcCtD
Efavirenz—Gastrointestinal pain—Vincristine—colon cancer	0.000604	0.00144	CcSEcCtD
Efavirenz—Decreased appetite—Fluorouracil—colon cancer	0.000599	0.00143	CcSEcCtD
Efavirenz—Alopecia—Capecitabine—colon cancer	0.000599	0.00143	CcSEcCtD
Efavirenz—Pancytopenia—Methotrexate—colon cancer	0.000599	0.00143	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000595	0.00142	CcSEcCtD
Efavirenz—Feeling abnormal—Irinotecan—colon cancer	0.000593	0.00142	CcSEcCtD
Efavirenz—Erythema—Capecitabine—colon cancer	0.00059	0.00141	CcSEcCtD
Efavirenz—Malnutrition—Capecitabine—colon cancer	0.00059	0.00141	CcSEcCtD
Efavirenz—Pain—Fluorouracil—colon cancer	0.00059	0.00141	CcSEcCtD
Efavirenz—Gastrointestinal pain—Irinotecan—colon cancer	0.000589	0.00141	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Methotrexate—colon cancer	0.000586	0.0014	CcSEcCtD
Efavirenz—Abdominal pain—Vincristine—colon cancer	0.000584	0.0014	CcSEcCtD
Efavirenz—Body temperature increased—Vincristine—colon cancer	0.000584	0.0014	CcSEcCtD
Efavirenz—Flatulence—Capecitabine—colon cancer	0.000582	0.00139	CcSEcCtD
Efavirenz—Dysgeusia—Capecitabine—colon cancer	0.000578	0.00138	CcSEcCtD
Efavirenz—Photosensitivity reaction—Methotrexate—colon cancer	0.000576	0.00138	CcSEcCtD
Efavirenz—Back pain—Capecitabine—colon cancer	0.000571	0.00136	CcSEcCtD
Efavirenz—Abdominal pain—Irinotecan—colon cancer	0.000569	0.00136	CcSEcCtD
Efavirenz—Body temperature increased—Irinotecan—colon cancer	0.000569	0.00136	CcSEcCtD
Efavirenz—Feeling abnormal—Fluorouracil—colon cancer	0.000568	0.00136	CcSEcCtD
Efavirenz—Pneumonia—Methotrexate—colon cancer	0.000566	0.00135	CcSEcCtD
Efavirenz—Infestation NOS—Methotrexate—colon cancer	0.000562	0.00134	CcSEcCtD
Efavirenz—Drowsiness—Methotrexate—colon cancer	0.000562	0.00134	CcSEcCtD
Efavirenz—Infestation—Methotrexate—colon cancer	0.000562	0.00134	CcSEcCtD
Efavirenz—Depression—Methotrexate—colon cancer	0.000561	0.00134	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000558	0.00133	CcSEcCtD
Efavirenz—Vision blurred—Capecitabine—colon cancer	0.000556	0.00133	CcSEcCtD
Efavirenz—Tremor—Capecitabine—colon cancer	0.000553	0.00132	CcSEcCtD
Efavirenz—Renal failure—Methotrexate—colon cancer	0.000553	0.00132	CcSEcCtD
Efavirenz—Ill-defined disorder—Capecitabine—colon cancer	0.000548	0.00131	CcSEcCtD
Efavirenz—Urticaria—Fluorouracil—colon cancer	0.000548	0.00131	CcSEcCtD
Efavirenz—Anaemia—Capecitabine—colon cancer	0.000546	0.0013	CcSEcCtD
Efavirenz—Body temperature increased—Fluorouracil—colon cancer	0.000545	0.0013	CcSEcCtD
Efavirenz—Hypersensitivity—Vincristine—colon cancer	0.000545	0.0013	CcSEcCtD
Efavirenz—Sweating—Methotrexate—colon cancer	0.000539	0.00129	CcSEcCtD
Efavirenz—Haematuria—Methotrexate—colon cancer	0.000536	0.00128	CcSEcCtD
Efavirenz—Malaise—Capecitabine—colon cancer	0.000532	0.00127	CcSEcCtD
Efavirenz—Hepatobiliary disease—Methotrexate—colon cancer	0.000532	0.00127	CcSEcCtD
Efavirenz—Vertigo—Capecitabine—colon cancer	0.00053	0.00127	CcSEcCtD
Efavirenz—Hypersensitivity—Irinotecan—colon cancer	0.00053	0.00127	CcSEcCtD
Efavirenz—Asthenia—Vincristine—colon cancer	0.00053	0.00127	CcSEcCtD
Efavirenz—Syncope—Capecitabine—colon cancer	0.000529	0.00127	CcSEcCtD
Efavirenz—Palpitations—Capecitabine—colon cancer	0.000522	0.00125	CcSEcCtD
Efavirenz—Loss of consciousness—Capecitabine—colon cancer	0.000519	0.00124	CcSEcCtD
Efavirenz—Asthenia—Irinotecan—colon cancer	0.000516	0.00123	CcSEcCtD
Efavirenz—Cough—Capecitabine—colon cancer	0.000515	0.00123	CcSEcCtD
Efavirenz—Hypertension—Capecitabine—colon cancer	0.00051	0.00122	CcSEcCtD
Efavirenz—Hypersensitivity—Fluorouracil—colon cancer	0.000508	0.00121	CcSEcCtD
Efavirenz—Diarrhoea—Vincristine—colon cancer	0.000506	0.00121	CcSEcCtD
Efavirenz—Hepatitis—Methotrexate—colon cancer	0.000505	0.00121	CcSEcCtD
Efavirenz—Arthralgia—Capecitabine—colon cancer	0.000503	0.0012	CcSEcCtD
Efavirenz—Chest pain—Capecitabine—colon cancer	0.000503	0.0012	CcSEcCtD
Efavirenz—Myalgia—Capecitabine—colon cancer	0.000503	0.0012	CcSEcCtD
Efavirenz—Anxiety—Capecitabine—colon cancer	0.000501	0.0012	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000499	0.00119	CcSEcCtD
Efavirenz—Urinary tract disorder—Methotrexate—colon cancer	0.000499	0.00119	CcSEcCtD
Efavirenz—Discomfort—Capecitabine—colon cancer	0.000497	0.00119	CcSEcCtD
Efavirenz—Urethral disorder—Methotrexate—colon cancer	0.000495	0.00118	CcSEcCtD
Efavirenz—Diarrhoea—Irinotecan—colon cancer	0.000493	0.00118	CcSEcCtD
Efavirenz—Dry mouth—Capecitabine—colon cancer	0.000492	0.00117	CcSEcCtD
Efavirenz—Dizziness—Vincristine—colon cancer	0.000489	0.00117	CcSEcCtD
Efavirenz—Pruritus—Fluorouracil—colon cancer	0.000488	0.00117	CcSEcCtD
Efavirenz—Visual impairment—Methotrexate—colon cancer	0.000486	0.00116	CcSEcCtD
Efavirenz—Confusional state—Capecitabine—colon cancer	0.000486	0.00116	CcSEcCtD
Efavirenz—Erythema multiforme—Methotrexate—colon cancer	0.000477	0.00114	CcSEcCtD
Efavirenz—Dizziness—Irinotecan—colon cancer	0.000476	0.00114	CcSEcCtD
Efavirenz—Shock—Capecitabine—colon cancer	0.000474	0.00113	CcSEcCtD
Efavirenz—Nervous system disorder—Capecitabine—colon cancer	0.000472	0.00113	CcSEcCtD
Efavirenz—Eye disorder—Methotrexate—colon cancer	0.000472	0.00113	CcSEcCtD
Efavirenz—Diarrhoea—Fluorouracil—colon cancer	0.000472	0.00113	CcSEcCtD
Efavirenz—Thrombocytopenia—Capecitabine—colon cancer	0.000472	0.00113	CcSEcCtD
Efavirenz—Tinnitus—Methotrexate—colon cancer	0.000471	0.00112	CcSEcCtD
Efavirenz—Tachycardia—Capecitabine—colon cancer	0.00047	0.00112	CcSEcCtD
Efavirenz—Vomiting—Vincristine—colon cancer	0.00047	0.00112	CcSEcCtD
Efavirenz—Cardiac disorder—Methotrexate—colon cancer	0.000469	0.00112	CcSEcCtD
Efavirenz—Skin disorder—Capecitabine—colon cancer	0.000468	0.00112	CcSEcCtD
Efavirenz—Rash—Vincristine—colon cancer	0.000466	0.00111	CcSEcCtD
Efavirenz—Hyperhidrosis—Capecitabine—colon cancer	0.000466	0.00111	CcSEcCtD
Efavirenz—Dermatitis—Vincristine—colon cancer	0.000466	0.00111	CcSEcCtD
Efavirenz—Headache—Vincristine—colon cancer	0.000463	0.00111	CcSEcCtD
Efavirenz—Anorexia—Capecitabine—colon cancer	0.000459	0.0011	CcSEcCtD
Efavirenz—Angiopathy—Methotrexate—colon cancer	0.000458	0.00109	CcSEcCtD
Efavirenz—Vomiting—Irinotecan—colon cancer	0.000458	0.00109	CcSEcCtD
Efavirenz—Immune system disorder—Methotrexate—colon cancer	0.000456	0.00109	CcSEcCtD
Efavirenz—Dizziness—Fluorouracil—colon cancer	0.000456	0.00109	CcSEcCtD
Efavirenz—Mediastinal disorder—Methotrexate—colon cancer	0.000455	0.00109	CcSEcCtD
Efavirenz—Rash—Irinotecan—colon cancer	0.000454	0.00108	CcSEcCtD
Efavirenz—Dermatitis—Irinotecan—colon cancer	0.000453	0.00108	CcSEcCtD
Efavirenz—Headache—Irinotecan—colon cancer	0.000451	0.00108	CcSEcCtD
Efavirenz—Alopecia—Methotrexate—colon cancer	0.000446	0.00107	CcSEcCtD
Efavirenz—Erythema—Methotrexate—colon cancer	0.000439	0.00105	CcSEcCtD
Efavirenz—Malnutrition—Methotrexate—colon cancer	0.000439	0.00105	CcSEcCtD
Efavirenz—Nausea—Vincristine—colon cancer	0.000439	0.00105	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000439	0.00105	CcSEcCtD
Efavirenz—Vomiting—Fluorouracil—colon cancer	0.000438	0.00105	CcSEcCtD
Efavirenz—Insomnia—Capecitabine—colon cancer	0.000436	0.00104	CcSEcCtD
Efavirenz—Rash—Fluorouracil—colon cancer	0.000435	0.00104	CcSEcCtD
Efavirenz—Dermatitis—Fluorouracil—colon cancer	0.000434	0.00104	CcSEcCtD
Efavirenz—Paraesthesia—Capecitabine—colon cancer	0.000433	0.00103	CcSEcCtD
Efavirenz—Headache—Fluorouracil—colon cancer	0.000432	0.00103	CcSEcCtD
Efavirenz—Dysgeusia—Methotrexate—colon cancer	0.00043	0.00103	CcSEcCtD
Efavirenz—Dyspnoea—Capecitabine—colon cancer	0.00043	0.00103	CcSEcCtD
Efavirenz—Nausea—Irinotecan—colon cancer	0.000428	0.00102	CcSEcCtD
Efavirenz—Back pain—Methotrexate—colon cancer	0.000425	0.00102	CcSEcCtD
Efavirenz—Dyspepsia—Capecitabine—colon cancer	0.000424	0.00101	CcSEcCtD
Efavirenz—Decreased appetite—Capecitabine—colon cancer	0.000419	0.001	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Capecitabine—colon cancer	0.000416	0.000994	CcSEcCtD
Efavirenz—Fatigue—Capecitabine—colon cancer	0.000415	0.000993	CcSEcCtD
Efavirenz—Vision blurred—Methotrexate—colon cancer	0.000414	0.00099	CcSEcCtD
Efavirenz—Pain—Capecitabine—colon cancer	0.000412	0.000985	CcSEcCtD
Efavirenz—Constipation—Capecitabine—colon cancer	0.000412	0.000985	CcSEcCtD
Efavirenz—Nausea—Fluorouracil—colon cancer	0.00041	0.000979	CcSEcCtD
Efavirenz—Ill-defined disorder—Methotrexate—colon cancer	0.000408	0.000974	CcSEcCtD
Efavirenz—Anaemia—Methotrexate—colon cancer	0.000406	0.000971	CcSEcCtD
Efavirenz—Feeling abnormal—Capecitabine—colon cancer	0.000397	0.000949	CcSEcCtD
Efavirenz—Malaise—Methotrexate—colon cancer	0.000396	0.000947	CcSEcCtD
Efavirenz—Vertigo—Methotrexate—colon cancer	0.000395	0.000944	CcSEcCtD
Efavirenz—Gastrointestinal pain—Capecitabine—colon cancer	0.000394	0.000942	CcSEcCtD
Efavirenz—Cough—Methotrexate—colon cancer	0.000383	0.000916	CcSEcCtD
Efavirenz—Urticaria—Capecitabine—colon cancer	0.000383	0.000915	CcSEcCtD
Efavirenz—Abdominal pain—Capecitabine—colon cancer	0.000381	0.00091	CcSEcCtD
Efavirenz—Body temperature increased—Capecitabine—colon cancer	0.000381	0.00091	CcSEcCtD
Efavirenz—Convulsion—Methotrexate—colon cancer	0.000381	0.00091	CcSEcCtD
Efavirenz—Arthralgia—Methotrexate—colon cancer	0.000374	0.000894	CcSEcCtD
Efavirenz—Myalgia—Methotrexate—colon cancer	0.000374	0.000894	CcSEcCtD
Efavirenz—Chest pain—Methotrexate—colon cancer	0.000374	0.000894	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000372	0.000888	CcSEcCtD
Efavirenz—Discomfort—Methotrexate—colon cancer	0.00037	0.000883	CcSEcCtD
Efavirenz—Confusional state—Methotrexate—colon cancer	0.000362	0.000864	CcSEcCtD
Efavirenz—Hypersensitivity—Capecitabine—colon cancer	0.000355	0.000848	CcSEcCtD
Efavirenz—Nervous system disorder—Methotrexate—colon cancer	0.000352	0.000841	CcSEcCtD
Efavirenz—Thrombocytopenia—Methotrexate—colon cancer	0.000351	0.000839	CcSEcCtD
Efavirenz—Skin disorder—Methotrexate—colon cancer	0.000348	0.000833	CcSEcCtD
Efavirenz—Hyperhidrosis—Methotrexate—colon cancer	0.000347	0.000829	CcSEcCtD
Efavirenz—Asthenia—Capecitabine—colon cancer	0.000346	0.000826	CcSEcCtD
Efavirenz—Anorexia—Methotrexate—colon cancer	0.000342	0.000817	CcSEcCtD
Efavirenz—Pruritus—Capecitabine—colon cancer	0.000341	0.000815	CcSEcCtD
Efavirenz—Diarrhoea—Capecitabine—colon cancer	0.00033	0.000788	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000327	0.000781	CcSEcCtD
Efavirenz—Insomnia—Methotrexate—colon cancer	0.000324	0.000775	CcSEcCtD
Efavirenz—Paraesthesia—Methotrexate—colon cancer	0.000322	0.00077	CcSEcCtD
Efavirenz—Dyspnoea—Methotrexate—colon cancer	0.00032	0.000764	CcSEcCtD
Efavirenz—Somnolence—Methotrexate—colon cancer	0.000319	0.000762	CcSEcCtD
Efavirenz—Dizziness—Capecitabine—colon cancer	0.000319	0.000761	CcSEcCtD
Efavirenz—Dyspepsia—Methotrexate—colon cancer	0.000316	0.000754	CcSEcCtD
Efavirenz—Decreased appetite—Methotrexate—colon cancer	0.000312	0.000745	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Methotrexate—colon cancer	0.00031	0.00074	CcSEcCtD
Efavirenz—Fatigue—Methotrexate—colon cancer	0.000309	0.000739	CcSEcCtD
Efavirenz—Pain—Methotrexate—colon cancer	0.000307	0.000733	CcSEcCtD
Efavirenz—Vomiting—Capecitabine—colon cancer	0.000306	0.000732	CcSEcCtD
Efavirenz—Rash—Capecitabine—colon cancer	0.000304	0.000726	CcSEcCtD
Efavirenz—Dermatitis—Capecitabine—colon cancer	0.000303	0.000725	CcSEcCtD
Efavirenz—Headache—Capecitabine—colon cancer	0.000302	0.000721	CcSEcCtD
Efavirenz—Feeling abnormal—Methotrexate—colon cancer	0.000296	0.000706	CcSEcCtD
Efavirenz—Gastrointestinal pain—Methotrexate—colon cancer	0.000293	0.000701	CcSEcCtD
Efavirenz—Nausea—Capecitabine—colon cancer	0.000286	0.000684	CcSEcCtD
Efavirenz—Urticaria—Methotrexate—colon cancer	0.000285	0.000681	CcSEcCtD
Efavirenz—Abdominal pain—Methotrexate—colon cancer	0.000284	0.000678	CcSEcCtD
Efavirenz—Body temperature increased—Methotrexate—colon cancer	0.000284	0.000678	CcSEcCtD
Efavirenz—Hypersensitivity—Methotrexate—colon cancer	0.000264	0.000631	CcSEcCtD
Efavirenz—Asthenia—Methotrexate—colon cancer	0.000257	0.000615	CcSEcCtD
Efavirenz—Pruritus—Methotrexate—colon cancer	0.000254	0.000606	CcSEcCtD
Efavirenz—Diarrhoea—Methotrexate—colon cancer	0.000245	0.000586	CcSEcCtD
Efavirenz—Dizziness—Methotrexate—colon cancer	0.000237	0.000567	CcSEcCtD
Efavirenz—Vomiting—Methotrexate—colon cancer	0.000228	0.000545	CcSEcCtD
Efavirenz—Rash—Methotrexate—colon cancer	0.000226	0.00054	CcSEcCtD
Efavirenz—Dermatitis—Methotrexate—colon cancer	0.000226	0.00054	CcSEcCtD
Efavirenz—Headache—Methotrexate—colon cancer	0.000225	0.000537	CcSEcCtD
Efavirenz—Nausea—Methotrexate—colon cancer	0.000213	0.000509	CcSEcCtD
